Long Term Obligations (Tables)

6 Months Ended

Jun. 30, 2019

Secured Term Loan

Schedule of Future Principal Maturities of Secured Term Loan

As of June 30, 2019, the future principal maturities of our Secured Term Loan for each of the next five years are as follows (in thousands):

Year ended December 31,
2022	$	9,615
2023		9,615
2024		9,615
Thereafter		33,655
Total	$	62,500

HealthCare Royalty Partners and its Affiliates (“HCR”)

Schedule of Payment Obligations

Our payment obligations for HCR royalty-based debt are as follows (in thousands):

	June 30, 2019			December 31, 2018
Total repayment obligations	$	290,550		$	290,550
Less: interests to be accreted in future periods		(114,812	)		(125,851	)
Less: payments made		(3,716	)		(816	)
Carrying value of long term royalty-based debt		172,022			163,883
Less: current portion of royalties		(14,588	)		(8,627	)
Non-current portion of long term royalty-based debt	$	157,434		$	155,256

Bristol-Myers Squibb Company ("BMS") and Pfizer Inc. ("Pfizer")

Schedule of Payment Obligations

Our payment obligations for BMS and Pfizer Promissory Notes are as follows (in thousands):

	June 30, 2019			December 31, 2018
Total repayment obligations	$	62,500		$	62,500
Less: interests to be accreted in future periods		(7,003	)		(8,643	)
Less: payments made		(2,211	)		(497	)
Carrying value of notes payable		53,286			53,360
Less: current portion of royalties		(8,622	)		(5,062	)
Non-current portion of notes payable	$	44,664		$	48,298